Frontlight ResearchEarly access
CompletedPhase 3
Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study
Key facts
- Who runs it
- Centre Hospitalier Universitaire Amiens Picardie
- Where
- France12 sites in 1 countryChoose a country to see its sites
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 310 people enrolled
- Started
- 13 Sept 2024
- Ended
- 11 Sept 2025
- Type of study
- Interventional
- Record updated
- 2 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adult patients with septic shock defined as sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥65 mm Hg and having a serum lactate level >2 mmol/L (18 mg/dL) despite adequate volume resuscitation
Who cannot take part
- Immediate indication to start renal replacement therapy at the time of randomization
- Resuscitated cardiac arrest
- Known severe chronic kidney disease (clearance <30 ml /min) in the last 3 months preceding the setic shock or kidney transplant recipient
- Presence of inclusion criteria for more than 24 hours
- Hyperkalemia≥ 6.5 mmol /l, metabolic acidosis with pH <7.15 not controlled by medical treatment, diuretic resistant acute pulmonary edema or accumulation of a toxic requiring dialysis
- Formal indication of Nicotinamide supplementation according to the attending physician (eg pellagra, undernutrition, severe alcoholism)
- Moribund patient (estimated survival less than 24 hours)
- Patient admitted to intensive care for more than 5 days
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
to show the superiority of Nicotinamide supplementation compared to the placebo group, in patients with septic shock admitted to intensive care
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study.
- Record updated
- 2 June 2025